Skip to content

Exercise and Bright Light Treatment: Effects on Body Weight and Composition

Moderate Exercise and Bright Light Treatment in Overweight Individuals

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00384345
Enrollment
24
Registered
2006-10-06
Start date
2003-09-30
Completion date
2003-12-31
Last updated
2006-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatigue, Obesity

Keywords

bright light treatment, exercise, body fat index, mood, sleep, fatigue

Brief summary

Bright light therapy has been used to safely and effectively treat conditions such as Seasonal Affective Disorder and to regularize sleep in patients with circadian rhythm disorder. Based on evidence of the link between bright light, serotonin, mood and carbohydrate metabolism, it has been suggested that bright light therapy can improve weight loss but the literature on the subject is sparse. Further, the literature suggests that apart from any changes in mood and carbohydrate metabolism, bright light may reduce the unpleasant side-effects of exercise and increase compliance to an exercise program.

Detailed description

Objective: Increased physical activity is important given the concern over the growing rates of obesity. Bright light therapy has the potential to enhancing serotonin levels, impact on carbohydrate metabolism and reducing soreness and hyperthermia associated with physical activity. The aim of this study is to conduct a controlled investigation of the effects of bright light therapy and exercise on weight loss and body composition in overweight individuals. Research Methods and Procedures: Twenty-five overweight male and female subjects will be assigned to 6 weeks of moderate exercise with or without bright light treatment. Outcome measure included changes in body mass and body composition and ratings of mood, seasonality and sleep.

Interventions

DEVICEBright Light Therapy
BEHAVIORALExercise

Sponsors

The Litebook Company Ltd.
CollaboratorINDUSTRY
University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Overweight subjects * Subjects in otherwise good health * Subjects willing to participate in a 6-week moderate exercise program * Bedtime between 10pm and 12am; wake-up time between 6am and 8am * Score in the median range of the Morningness/ Eveningness Questionnaire (i.e., subjects show no distinct characteristics of phase delay or phase advance)

Exclusion criteria

* Progressive eye disease * History of cataracts, macular degeneration or have undergone laser corrective eye surgery in the past 30 days. * Currently taking any medications, e.g. antibiotics, tricyclic antidepressants, that may affect photosensitivity * History of heart disease * History of respiratory diseases, such as asthma, emphysema * Any severe or uncontrolled general medical condition * Severe psychiatric disorder (as determined by psychiatrist - CMS) * History of mania * Grossly obese individuals with morbid obesity

Design outcomes

Primary

MeasureTime frame
The primary outcome measure will be the amount of weight loss.

Secondary

MeasureTime frame
Secondary outcome measures will be the ratings of mood on the POMS, CES-D and SPAQ

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026